These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
534 related articles for article (PubMed ID: 18652994)
1. Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa. Sutcliffe CG; van Dijk JH; Bolton C; Persaud D; Moss WJ Lancet Infect Dis; 2008 Aug; 8(8):477-89. PubMed ID: 18652994 [TBL] [Abstract][Full Text] [Related]
2. HIV/AIDS care and treatment in sub-Saharan Africa. Kassaye SG; Katzenstein D AIDS Rev; 2003; 5(4):195-204. PubMed ID: 15011998 [TBL] [Abstract][Full Text] [Related]
3. Characteristics and response to antiretroviral therapy of HIV-1-infected patients born in Africa and living in France. Breton G; Lewden C; Spire B; Salmon D; Brun-Vézinet F; Duong M; Allavena C; Leport C; Salamon R; HIV Med; 2007 Apr; 8(3):164-70. PubMed ID: 17461860 [TBL] [Abstract][Full Text] [Related]
4. Challenges of malnutrition care among HIV-infected children on antiretroviral treatment in Africa. Jesson J; Leroy V Med Mal Infect; 2015 May; 45(5):149-56. PubMed ID: 25861689 [TBL] [Abstract][Full Text] [Related]
5. Antiretroviral therapy in HIV-infected infants and children. Marón G; Gaur AH; Flynn PM Pediatr Infect Dis J; 2010 Apr; 29(4):360-3. PubMed ID: 20351530 [No Abstract] [Full Text] [Related]
6. The status of HIV-1 resistance to antiretroviral drugs in sub-Saharan Africa. Hamers RL; Derdelinckx I; van Vugt M; Stevens W; Rinke de Wit TF; Schuurman R; Antivir Ther; 2008; 13(5):625-39. PubMed ID: 18771046 [TBL] [Abstract][Full Text] [Related]
7. Contemporary issues on the epidemiology and antiretroviral adherence of HIV-infected adolescents in sub-Saharan Africa: a narrative review. Adejumo OA; Malee KM; Ryscavage P; Hunter SJ; Taiwo BO J Int AIDS Soc; 2015; 18(1):20049. PubMed ID: 26385853 [TBL] [Abstract][Full Text] [Related]
8. Treating an HIV-infected paediatric patient: an easy task? Rakhmanina NY; van den Anker JN Antivir Ther; 2010; 15(3):293-6. PubMed ID: 20516549 [TBL] [Abstract][Full Text] [Related]
9. Antiretroviral drug resistance among HIV-1 infected children failing treatment. Mullen J; Leech S; O'Shea S; Chrystie IL; Du Mont G; Ball C; Sharland M; Cottam F; Zuckerman M; Rice P; Easterbrook P J Med Virol; 2002 Nov; 68(3):299-304. PubMed ID: 12226814 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of highly active antiretroviral therapy in HIV-infected children participating in Thailand's National Access to Antiretroviral Program. Puthanakit T; Oberdorfer A; Akarathum N; Kanjanavanit S; Wannarit P; Sirisanthana T; Sirisanthana V Clin Infect Dis; 2005 Jul; 41(1):100-7. PubMed ID: 15937769 [TBL] [Abstract][Full Text] [Related]
11. Estimate of infant HIV-free survival at 6 to 8 weeks of age due to maternal antiretroviral prophylaxis in Sub-Saharan Africa, 2004-2005. Boeke CE; Jackson JB J Int Assoc Physicians AIDS Care (Chic); 2008; 7(3):133-40. PubMed ID: 18460695 [TBL] [Abstract][Full Text] [Related]
12. Challenges and perspectives of compliance with pediatric antiretroviral therapy in Sub-Saharan Africa. Dahourou DL; Leroy V Med Mal Infect; 2017 Dec; 47(8):511-518. PubMed ID: 28943171 [TBL] [Abstract][Full Text] [Related]
13. The REVAMP trial to evaluate HIV resistance testing in sub-Saharan Africa: a case study in clinical trial design in resource limited settings to optimize effectiveness and cost effectiveness estimates. Siedner MJ; Bwana MB; Moosa MS; Paul M; Pillay S; McCluskey S; Aturinda I; Ard K; Muyindike W; Moodley P; Brijkumar J; Rautenberg T; George G; Johnson B; Gandhi RT; Sunpath H; Marconi VC HIV Clin Trials; 2017 Jul; 18(4):149-155. PubMed ID: 28720039 [TBL] [Abstract][Full Text] [Related]
14. Comparative evaluation of adherence to antiretroviral therapy in sub-Saharan African native HIV-infected patients in France and Africa. Sellier P; Clevenbergh P; Ljubicic L; Simoneau G; Evans J; Delcey V; Diemer M; Bendenoun M; Mouly S; Bergmann JF Clin Infect Dis; 2006 Sep; 43(5):654-7. PubMed ID: 16886162 [TBL] [Abstract][Full Text] [Related]
15. Virological follow-up of adult patients in antiretroviral treatment programmes in sub-Saharan Africa: a systematic review. Barth RE; van der Loeff MF; Schuurman R; Hoepelman AI; Wensing AM Lancet Infect Dis; 2010 Mar; 10(3):155-66. PubMed ID: 20185094 [TBL] [Abstract][Full Text] [Related]
16. [AIDS treatment in Africa: the risk of antiretroviral resistance]. Hamers RL; Schuurman R; van Vugt M; Derdelinckx I; Rinke de Wit TF Ned Tijdschr Geneeskd; 2007 Dec; 151(48):2666-71. PubMed ID: 18179083 [TBL] [Abstract][Full Text] [Related]
17. Incorporating loss to follow-up in estimates of survival among HIV-infected individuals in sub-Saharan Africa enrolled in antiretroviral therapy programs. Verguet S; Lim SS; Murray CJ; Gakidou E; Salomon JA J Infect Dis; 2013 Jan; 207(1):72-9. PubMed ID: 23100567 [TBL] [Abstract][Full Text] [Related]
18. Strategies to optimize HIV treatment outcomes in resource-limited settings. Nakanjako D; Colebunders R; Coutinho AG; Kamya MR AIDS Rev; 2009; 11(4):179-89. PubMed ID: 19940945 [TBL] [Abstract][Full Text] [Related]
19. Care and treatment of HIV-infected children in Africa: issues and challenges at the district hospital level. De Baets AJ; Bulterys M; Abrams EJ; Kankassa C; Pazvakavambwa IE Pediatr Infect Dis J; 2007 Feb; 26(2):163-73. PubMed ID: 17259881 [TBL] [Abstract][Full Text] [Related]
20. Characteristics and comprehensiveness of adult HIV care and treatment programmes in Asia-Pacific, sub-Saharan Africa and the Americas: results of a site assessment conducted by the International epidemiologic Databases to Evaluate AIDS (IeDEA) Collaboration. Duda SN; Farr AM; Lindegren ML; Blevins M; Wester CW; Wools-Kaloustian K; Ekouevi DK; Egger M; Hemingway-Foday J; Cooper DA; Moore RD; McGowan CC; Nash D; J Int AIDS Soc; 2014; 17(1):19045. PubMed ID: 25516092 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]